Ritiometan
Ritiometan
|
Systematic (IUPAC) name |
---|
2,2',2''-(methanetriyltrisulfanediyl)triacetic acid |
Clinical data |
---|
Trade names |
Nécyrane |
---|
AHFS/Drugs.com |
International Drug Names |
---|
|
Topical (intranasal) |
---|
Identifiers |
---|
|
34914-39-1 |
---|
|
R01AX05 |
---|
PubChem |
CID 65787 |
---|
ChemSpider |
59206 Y |
---|
UNII |
J89LM8QVEE Y |
---|
Synonyms |
(Methylidynetrithio)triacetic acid |
---|
Chemical data |
---|
Formula |
C7H10O6S3 |
---|
|
286.346 g/mol |
---|
SMILES
- O=C(O)CSC(SCC(=O)O)SCC(=O)O
|
InChI=1S/C7H10O6S3/c8-4(9)1-14-7(15-2-5(10)11)16-3-6(12)13/h7H,1-3H2,(H,8,9)(H,10,11)(H,12,13)
Y
Key:ZBNBQISDCFIEQC-UHFFFAOYSA-N
Y
|
Y (what is this?) (verify) |
---|
Ritiometan is an antibacterial used in nasal sprays.[1] It is marketed in France under the trade name Nécyrane.[2]
References
|
---|
| Topical | Sympathomimetics, plain | |
---|
| | |
---|
| | |
---|
| Other nasal preparations | |
---|
|
---|
| Systemic use: Sympathomimetics | |
---|
| |
---|
| Description |
- Anatomy
- Physiology
- Development
|
---|
| Disease |
- Congenital
- Neoplasms and cancer
- Chest trauma
- Infection
- common cold
- pneumonia
- tuberculosis
- Other
- Symptoms and signs
|
---|
| Treatment |
- Procedures
- Drugs
- nasal
- throat
- obstructive airway diseases
- cough and cold
- histaminergics
- pulmonary arterial hypertension
- other
- Surgery
|
---|
|
|